Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$14.29 0.08 | 0.56%
03/29/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 146.69M 135.06M 75.33M 54.80M
Cost of Sales 30.24M 26.69M 19.51M 3.90M
Gross Operating Profit 116.45M 108.37M 55.82M 50.90M
Selling, General, and Administrative Expenses 45.85M 40.03M 35.94M 32.35M
Research & Development 150.84M 93.24M 79.70M 96.64M
Operating Income before D & A (EBITDA) -80.25M -24.90M -59.82M -78.09M
Depreciation & Amortization 2.96M 2.56M 3.22M 2.34M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.33M 422.00K 242.00K 229.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -81.88M -27.03M -62.79M -80.20M
Interest Expense 19.98M 5.20M 5.58M 3.27M
Pre-Tax Income -101.86M -32.23M -68.38M -83.48M
Income Taxes 1.16M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -103.02M -32.23M -68.38M -83.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -103.02M -32.23M -68.38M -83.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -103.02M -32.23M -68.38M -83.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-103.02M -32.23M -68.38M -83.48M
Preferred Dividends
Net Income Available To Common -103.02M -32.23M -68.38M -83.48M
Basic EPS from Continuing Ops. -0.81 -0.25 -0.56 -0.74
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.81 -0.25 -0.56 -0.74
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.81 -0.25 -0.56 -0.74
Basic Normalized Net Income/Share -0.81 -0.25 -0.56 -0.74
EPS fr Continuing Ops. -0.81 -0.25 -0.56 -0.74
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.81 -0.25 -0.56 -0.74
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.81 -0.25 -0.56 -0.74
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.81 -0.25 -0.56 -0.74
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter